Physician profile
Edwin R Ramirez
NPI 1558683920
$91,568.06
in general payments reported to CMS, 2019-2025
20 companies · $784 in 2025
The $784 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $17K · 2021: $18K · 2022: $8,850 · 2023: $771 · 2024: $3,893 · 2025: $784.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,925 · Food and Beverage: $2,508 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,925.00 |
| Food and Beverage | $2,508.19 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $44,840.50 | 2019-2024 | Olympus, 4k Cable 8.5m |
| Abbvie INC. | $35,379.63 | 2019-2023 | |
| Olympus America INC. | $5,100.00 | 2019-2020 | |
| Intuitive Surgical, INC. | $2,551.47 | 2019-2025 | |
| Olympus Latin America, INC. | $1,050.00 | 2021 | |
| Pfizer INC. | $506.31 | 2021-2024 | |
| Karl Storz Imaging, INC. | $500.00 | 2020 | |
| Sumitomo Pharma America, INC. | $371.48 | 2023-2025 | Myfembree |
| Femselect INC. | $327.76 | 2023-2025 | Enplace |
| Karl Storz Endoscopy-America | $229.22 | 2021-2025 | Hopkins |
| Hologic Sales and Service, LLC | $195.90 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $192.98 | 2025 | |
| Coopersurgical, INC. | $156.66 | 2019-2023 | Mara Console |
| Coloplast Corp | $45.45 | 2020-2021 | |
| Meditrina | $31.96 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $26.12 | 2025 | |
| Mimedx Group, INC. | $22.63 | 2025 | |
| Myovant Sciences INC. | $20.70 | 2022 | |
| Biom'Up France Sas | $19.29 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.